Pharmacists Improving Treatment Adherence & Patient Outcomes in Atopic Dermatitis (AD)

A free online accredited CPD program for Canadian Pharmacists

Up to 17% of Canadians will develop AD during their lifetime.

A patient with atopic dermatitis Up to 17% of Canadians will develop AD during their lifetime. AD or eczema can occur at any age but usually appears in early childhood with the possibility of disease flares occurring throughout a patient’s adulthood.
AD affects both the patient and their family with its ongoing itch-scratch cycle that compromises sleep and negatively affects quality of life.
AD treatment focuses on the immediate need of treating an acute flare’s itch and inflammation with the long-term goal of promoting maintenance of the skin barrier. The treatment approach includes prescribed topical treatment, proper skin hydration and a long-term skin care program.
Program Planning Committee
Adam Natsheh, MD, FRCPC (Derm), BSc (Pharm)
Ron Pohar, BScPharm, APA
Brad Couldwell, BScPharm., APA, CDE, CTH
1 CEU CCCEP & 1 CEU OPQ
Program available online until: September 19, 2017
Taking a stepped approach to AD management chart.

Course Learning Objectives

  • Identify the key aspects of diagnosing and treating eczema, specifically atopic dermatitis (AD).
  • Describe the safe and appropriate use of various treatment options, including the important role of topical calcineurin inhibitors (TCI) in achieving and maintaining control of eczema.
  • Improve treatment adherence and patient outcomes in eczema through effective counselling, patient education, and by utilizing the pharmacist scope of practice.

Questions answered by our expert: David Adam, MD, FRCPC

  • What are the recommendations for treating AD flares?
  • What are the major adherence issues when using topical corticosteroids (TCs) or topical calcineurin inhibitors (TCIs)?
  • What are the important differences between use of topical corticosteroids (TCs) and topical calcineurin inhibitors (TCIs)?
  • What is the best approach for the maintenance of AD therapy?
Video Expert David Adam answers questions related to Atopic Dermatitis (AD)

rxBriefCase is the practical choice to earn your CPD Credits

Icon of multiple pages
Over 50 accredited courses on rxBriefCase and our sister sites.
The range of courses we offer is unmatched. In addition to our courses we offer accredited newsletters and resource centres. With 22 therapeutic categories, we are sure to expand your medical knowledge.
Icon of a clock
Save Time and Money
Take public transit to work? Like to read in the park? You can access our courses anywhere and earn your CPD credits, all at no cost for you.

Join 100,000+ of your colleagues

Create your free rxBriefCase account today